KRMD vs PATH
Repro Med Systems Inc (KRMD) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Repro Med Systems Inc (KRMD) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported KRMD revenue for 2024-12-31 was $33.6M. Net income was -$6.1M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. KRMD currently screens at market cap $186.0M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
KRMD currently screens at market cap $186.0M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the KRMD and PATH stock pages for the full models.
Not investment advice.